This work wouldn't have been possible without the amazing work from everyone who helped with the project, the input from patient advocates including Lianne Kraemer, and the guidance and mentorship of @cittellylab.bsky.social
Check it out!
www.nature.com/articles/s41...
nature.com
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases - Nature Communications
FGFR1 amplifications are associated with risk of late recurrence for estrogen receptor-positive breast cancer. Here, the authors show that the brain microenvironment modulates FGFR1 activity in a host...
